Overlapping network meta-analyses on the same topic: Survey of published studies

International Journal of Epidemiology

Volumn 46, Issue 6, 2017, Pages 1999-2008

  Naudet, F ^a   Schuit, E ^a,b   Ioannidis, J P A ^a,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Evidence based medicine; Network meta analysis; Randomized controlled trials

Indexed keywords

BIOLOGICAL PRODUCT;

ANALYTICAL METHOD; DATA SET; DISEASE TREATMENT; EXPERIMENTAL STUDY; GEOMETRY; HEALTH SURVEY; MEDICINE; META-ANALYSIS; NETWORK ANALYSIS;

ARTICLE; CLINICAL EFFECTIVENESS; CONFIDENCE INTERVAL; DATA ANALYSIS; EVALUATION STUDY; GEOMETRY; HUMAN; INFORMATION PROCESSING; INTERVENTION STUDY; META ANALYSIS; NETWORK META-ANALYSIS; PATIENT PARTICIPATION; PRIORITY JOURNAL; PUBLISHING; RANDOM SAMPLE; RHEUMATOID ARTHRITIS; EVIDENCE BASED MEDICINE; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

EVIDENCE-BASED MEDICINE; HUMANS; NETWORK META-ANALYSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 85039550125     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyx138     Document Type: Article

References (30)

1. Mills EJ, Thorlund K, Ioannidis JP. Demystifying trial networks and network meta-analysis. BMJ 2013;346:f2914
2. Neupane B, Richer D, Bonner AJ, Kibret T, Beyene J. Network meta-analysis using R:a review of currently available automated packages. PLoS One 2014;9:e115065
3. Nikolakopoulou A, Chaimani A, Veroniki AA, Vasiliadis HS, Schmid CH, Salanti G. Characteristics of networks of interventions: a description of a database of 186 published networks. PLoS One 2014;9:e86754
4. Bafeta A, Trinquart L, Seror R, Ravaud P. Analysis of the systematic reviews process in reports of network meta-analyses: methodological systematic review. BMJ 2013;347:f3675
5. Siontis KC, Hernandez-Boussard T, Ioannidis JP. Overlapping meta-analyses on the same topic:survey of published studies. BMJ 2013;347:f4501
6. Schuit E, Ioannidis JP. Network meta-analyses performed by contracting companies and commissioned by industry. Systematic Reviews (In Press) 2016
7. Salanti G, Kavvoura FK, Ioannidis JP. Exploring the geometry of treatment networks. Ann Intern Med 2008;148:544-53
8. Ioannidis JP. Why most discovered true associations are inflated. Epidemiology 2008;19:640-8
9. Patel CJ, Burford B, Ioannidis JP. Assessment of vibration of effects due to model specification can demonstrate the instability of observational associations. J Clin Epidemiol 2015;68: 1046-58
10. Ioannidis JP, Horbar JD, Ovelman CM et al. Completeness of main outcomes across randomized trials in entire discipline:survey of chronic lung disease outcomes in preterm infants. BMJ 2015;350:h72
11. Williamson P, Clarke M. The COMET (Core Outcome Measures in Effectiveness Trials) Initiative:its role in improving Cochrane Reviews. Cochrane Database Syst Rev 2012: ED000041
12. Williamson PR, Altman DG, Blazeby JM et al. Developing core outcome sets for clinical trials:issues to consider. Trials 2012;13: 132
13. Ioannidis JP. The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses. Milbank Q 2016;94:485-514
14. Mills EJ, Kanters S, Thorlund K, Chaimani A, Veroniki AA, Ioannidis JP. The effects of excluding treatments from network meta-analyses:survey. BMJ 2013;347:f5195
15. Trinquart L, Abbe A, Ravaud P. Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials. PLoS One 2012;7:e35219
16. Owen RK, Tincello DG, Keith RA. Network meta-analysis: development of a three-level hierarchical modeling approach incorporating dose-related constraints. Value Health 2015;18: 116-26
17. Del Giovane C Vacchi, L Mavridis, D Filippini, G Salanti, G. Network meta-analysis models to account for variability in treatment definitions:application to dose effects. Stat Med 2013;32: 25-39
18. Karassa FB, Ioannidis JP. Clinical trials:A transparent future for clinical trial reporting. Nat Rev Rheumatol 2015;11: 324-6
19. Ioannidis JP, Karassa FB, Druyts E, Thorlund K, Mills EJ. Biologic agents in rheumatology:unmet issues after 200 trials and $200 billion sales. Nat Rev Rheumatol 2013;9:665-73
20. Ioannidis JP, Karassa FB. The need to consider the wider agenda in systematic reviews and meta-analyses:breadth, timing, and depth of the evidence. BMJ 2010;341:c4875
21. Flacco ME, Manzoli L, Boccia S et al. Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor. J Clin Epidemiol 2015;68:811-20
22. Thorlund K, Druyts E, Avina-Zubieta JA, Wu P, Mills EJ. Why the findings of published multiple treatment comparison metaanalyses of biologic treatments for rheumatoid arthritis are different: an overview of recurrent methodological shortcomings. Ann Rheum Dis 2013;72:1524-35
23. Krumholz H. The case for duplication of meta-analyses and systematic reviews. BMJ 2013;347:f5506
24. Patsopoulos NA, Ioannidis JP. The use of older studies in metaanalyses of medical interventions:a survey. Open Med 2009;3: e62-8
25. Dias S, Welton NJ, Sutton AJ, Ades AE. Evidence synthesis for decision making 1:introduction. Med Decis Making 2013;33: 597-606
26. PROSPERO:International Prospective Register Of Systematic Reviews. [cited 2016 November 2];Available from:http://www. crd.york.ac.uk/PROSPERO/#index.php
27. Ebrahim S, Bance S, Athale A, Malachowski C, Ioannidis JP. Meta-analyses with industry involvement are massively published and report no caveats for antidepressants. J Clin Epidemiol 2016;70:155-63
28. Jorgensen AW, Hilden J, Gotzsche PC. Cochrane reviews compared with industry supported meta-analyses and other metaanalyses of the same drugs:systematic review. BMJ 2006;333: 782
29. Crequit P, Trinquart L, Yavchitz A, Ravaud P. Wasted research when systematic reviews fail to provide a complete and up-todate evidence synthesis:the example of lung cancer. BMC Med 2016;14:8
30. Vandvik PO, Brignardello-Petersen R, Guyatt GH. Living cumulative network meta-analysis to reduce waste in research: A paradigmatic shift for systematic reviews? BMC Med 2016; 14:59